Jim Bush

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2

Wendy Painter, Wayne Holman, Jim Bush et al. · Antimicrobial Agents and Chemotherapy · 2021 · 391 citations · Full text

Adverse Events, Geometric Half-life, Pharmacology +13

Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring

Nick L. Occleston, Sharon O’Kane, Hugh Laverty et al. · Wound Repair and Regeneration · 2011 · 78 citations

Randomized phase II clinical trial of avotermin <i>versus</i> placebo for scar improvement

P T McCollum, Jim Bush, G James et al. · British journal of surgery · 2011 · 47 citations · Full text

Dietary fat supplementation effects on in vitro nutrient disappearance and in vivo nutrient intake and total tract digestibility by horses.

Jim Bush, David E. Freeman, K.H. Kline et al. · Journal of Animal Science · 2001 · 45 citations

Nutrition, Agricultural Economics, Education +19

Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects

Tomohiko Harada, Darren Wilbraham, Guillemette de La Borderie et al. · British Journal of Clinical Pharmacology · 2016 · 35 citations · Full text